Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD38 positive
i
Other names:
CD38, CD38 Molecule, ADP-Ribosyl Cyclase 1, ADP-Ribosyl Cyclase/Cyclic ADP-Ribose Hydrolase 1, 2'-Phospho-Cyclic-ADP-Ribose Transferase, 2'-Phospho-ADP-Ribosyl Cyclase, Cyclic ADP-Ribose Hydrolase 1, NAD(+) Nucleosidase, CD38 Antigen (P45), ADPRC 1, 2'-Phospho-ADP-Ribosyl Cyclase/2'-Phospho-Cyclic-ADP-Ribose Transferase, Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase, Cluster Of Differentiation 38, CADPr Hydrolase 1, CD38 Antigen, ADPRC1, T10
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
952
Related biomarkers:
Expression
Others
‹
›
Associations
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
CD38 positive
Multiple Myeloma
CD38 positive
Multiple Myeloma
SAR442257
Sensitive: D – Preclinical
EHA 2023 - 2 weeks (New D)
SAR442257
Sensitive
:
D
EHA 2023 - 2wk
SAR442257
Sensitive: D – Preclinical
EHA 2023 - 2 weeks
SAR442257
Sensitive
:
D
EHA 2023 - 2 weeks - (New D)
CD38 positive
Multiple Myeloma
CD38 positive
Multiple Myeloma
daratumumab
Sensitive: C3 – Early Trials
daratumumab
Sensitive
:
C3
daratumumab
Sensitive: C3 – Early Trials
daratumumab
Sensitive
:
C3
CD38 positive
Multiple Myeloma
CD38 positive
Multiple Myeloma
isatuximab-irfc + K-NK004
Sensitive: D – Preclinical
isatuximab-irfc + K-NK004
Sensitive
:
D
isatuximab-irfc + K-NK004
Sensitive: D – Preclinical
isatuximab-irfc + K-NK004
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login